Innoviva Inc (INVA)
19.08
-0.08
(-0.39%)
USD |
NASDAQ |
Nov 21, 16:00
19.08
0.00 (0.00%)
After-Hours: 20:00
Innoviva Market Cap: 1.194B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.199B |
| November 19, 2024 | 1.195B |
| November 18, 2024 | 1.186B |
| November 15, 2024 | 1.183B |
| November 14, 2024 | 1.204B |
| November 13, 2024 | 1.258B |
| November 12, 2024 | 1.272B |
| November 11, 2024 | 1.260B |
| November 08, 2024 | 1.263B |
| November 07, 2024 | 1.252B |
| November 06, 2024 | 1.247B |
| November 05, 2024 | 1.216B |
| November 04, 2024 | 1.212B |
| November 01, 2024 | 1.206B |
| October 31, 2024 | 1.224B |
| October 30, 2024 | 1.234B |
| October 29, 2024 | 1.245B |
| October 28, 2024 | 1.248B |
| October 25, 2024 | 1.238B |
| October 24, 2024 | 1.239B |
| October 23, 2024 | 1.241B |
| October 22, 2024 | 1.250B |
| October 21, 2024 | 1.243B |
| October 18, 2024 | 1.254B |
| October 17, 2024 | 1.263B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.265B |
| October 15, 2024 | 1.245B |
| October 14, 2024 | 1.245B |
| October 11, 2024 | 1.239B |
| October 10, 2024 | 1.220B |
| October 09, 2024 | 1.230B |
| October 08, 2024 | 1.241B |
| October 07, 2024 | 1.236B |
| October 04, 2024 | 1.231B |
| October 03, 2024 | 1.221B |
| October 02, 2024 | 1.224B |
| October 01, 2024 | 1.221B |
| September 30, 2024 | 1.209B |
| September 27, 2024 | 1.209B |
| September 26, 2024 | 1.185B |
| September 25, 2024 | 1.180B |
| September 24, 2024 | 1.182B |
| September 23, 2024 | 1.183B |
| September 20, 2024 | 1.211B |
| September 19, 2024 | 1.231B |
| September 18, 2024 | 1.222B |
| September 17, 2024 | 1.233B |
| September 16, 2024 | 1.254B |
| September 13, 2024 | 1.239B |
| September 12, 2024 | 1.227B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
730.99M
Minimum
Mar 09 2023
1.546B
Maximum
Jun 22 2020
1.086B
Average
1.066B
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 17.79M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.561M |
| Oragenics Inc | 3.301M |
Market Cap Related Metrics
| PE Ratio | 27.64 |
| PS Ratio | 3.988 |
| PEG Ratio | 0.4866 |
| Price to Book Value | 1.786 |
| Price to Free Cash Flow | 8.669 |
| Price | 19.08 |
| Earnings Yield | 3.62% |
| PEGY Ratio | 0.4866 |
| Operating PE Ratio | 8.724 |
| Normalized PE Ratio | 14.53 |